Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANDESARTAN Cause Intentional product use issue? 1,072 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,072 reports of Intentional product use issue have been filed in association with CANDESARTAN. This represents 11.9% of all adverse event reports for CANDESARTAN.

1,072
Reports of Intentional product use issue with CANDESARTAN
11.9%
of all CANDESARTAN reports
697
Deaths
695
Hospitalizations

How Dangerous Is Intentional product use issue From CANDESARTAN?

Of the 1,072 reports, 697 (65.0%) resulted in death, 695 (64.8%) required hospitalization, and 686 (64.0%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 1,072 reports have been filed with the FAERS database.

What Other Side Effects Does CANDESARTAN Cause?

Off label use (1,911) Fatigue (1,468) Dyspnoea (1,456) Pain (1,455) Drug ineffective (1,428) Headache (1,371) Nausea (1,282) Dizziness (1,237) Vomiting (1,202) Diarrhoea (1,145)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which CANDESARTAN Alternatives Have Lower Intentional product use issue Risk?

CANDESARTAN vs CANDESARTAN CILEXETIL CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANDESARTAN vs CANGRELOR CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN CANDESARTAN vs CANNABIDIOL

Related Pages

CANDESARTAN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue CANDESARTAN Demographics